Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,385 | 9,821 | 12,432 | 12,383 | 10,495 |
| TOTAL | $134,221 | $10,494 | $13,328 | $14,733 | $11,506 |
| Non-Current Assets | |||||
| PPE Net | N/A | 3 | 10 | 10 | 3 |
| Other Non-Current Assets | 123 | 383 | 714 | 1,020 | 1,003 |
| TOTAL | $123 | $386 | $724 | $1,030 | $1,006 |
| Total Assets | $134,344 | $10,880 | $14,052 | $15,763 | $12,512 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 384 | 79 | 158 | 88 | 87 |
| Accounts payable and accrued liabilities | 767 | 1,105 | 698 | 1,759 | 1,323 |
| Accrued Expenses | 3,485 | 1,962 | 1,609 | 1,060 | 974 |
| TOTAL | $4,636 | $3,236 | $2,586 | $3,012 | $2,496 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 328 | 152 | 153 | 272 | 2,651 |
| TOTAL | $328 | $152 | $153 | $272 | $2,651 |
| Total Liabilities | $4,964 | $3,388 | $2,739 | $3,284 | $5,147 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 165,885 | 4,397 | 852 | 300 | 24 |
| Common Shares | 1,594 | 27 | 6 | 30 | 3 |
| Retained earnings | -152,725 | -135,944 | -121,506 | -109,190 | -94,642 |
| Other shareholders' equity | 2 | 2 | 2 | 2 | 2 |
| TOTAL | $129,380 | $7,492 | $11,313 | $12,479 | $7,365 |
| Total Liabilities And Equity | $134,344 | $10,880 | $14,052 | $15,763 | $12,512 |